102 related articles for article (PubMed ID: 3130179)
41. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
[TBL] [Abstract][Full Text] [Related]
42. High dose-rate brachytherapy for elderly patients with uterine cervical cancer.
Chen SW; Liang JA; Yang SN; Lin FJ
Jpn J Clin Oncol; 2003 May; 33(5):221-8. PubMed ID: 12865465
[TBL] [Abstract][Full Text] [Related]
43. The treatment of stage IV carcinoma of cervix by radical dose radiotherapy.
Upadhyay SK; Symonds RP; Haelterman M; Watson ER
Radiother Oncol; 1988 Jan; 11(1):15-9. PubMed ID: 2449706
[TBL] [Abstract][Full Text] [Related]
44. High dose rate Cobalt-60 after loading intracavitary therapy of the uterine cervical carcinoma in Srinagarind Hospital, analysis of residual disease.
Pesee M; Krusun S; Padoongcharoen P
Asian Pac J Cancer Prev; 2012; 13(9):4835-7. PubMed ID: 23167428
[TBL] [Abstract][Full Text] [Related]
45. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
46. [Neutron therapy of endometrial cancer using californium-252 sources of high activity].
Kiseleva VN; Savinova VF; Mar'ina LA; Chekhonadskiĭ VN
Vopr Onkol; 1988; 34(9):1070-4. PubMed ID: 3188432
[TBL] [Abstract][Full Text] [Related]
47. Second primary malignancies after radiotherapy including HDR (252)Cf brachytherapy for cervical cancer.
Samerdokiene V; Valuckas KP; Janulionis E; Atkocius V; Rivard MJ
Brachytherapy; 2015; 14(6):898-904. PubMed ID: 26194049
[TBL] [Abstract][Full Text] [Related]
48. Biologically effective doses from californium-252 intracavitary applications.
Iyer PS
Strahlentherapie; 1975 Feb; 149(2):185-7. PubMed ID: 806142
[TBL] [Abstract][Full Text] [Related]
49. Californium-252 neutron intracavity brachytherapy alone for T1N0 low-lying rectal adenocarcinoma: A definitive anal sphincter-preserving radiotherapy.
Xiong Y; Shan J; Liu J; Zhao K; Chen S; Xu W; Zhou Q; Yang M; Lei X
Sci Rep; 2017 Jan; 7():40619. PubMed ID: 28094790
[TBL] [Abstract][Full Text] [Related]
50. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience.
Rath GK; Sharma DN; Julka PK; Subramani V; Bahl A; Haresh KP
Am J Clin Oncol; 2010 Jun; 33(3):238-41. PubMed ID: 19841576
[TBL] [Abstract][Full Text] [Related]
51. [252Cf brachytherapy].
Sugiyama T; Kaneta K
Gan No Rinsho; 1983 May; 29(6):702-7. PubMed ID: 6876439
[TBL] [Abstract][Full Text] [Related]
52. New understanding from Cf brachytherapy trials and considerations for neutron therapy of bulky gyn carcinoma for future.
Maruyama Y; Mesina J; Yudelev M; Wierzbicki J; Deppe G; Porter AT
Strahlenther Onkol; 1994 May; 170(5):253-63. PubMed ID: 8197547
[TBL] [Abstract][Full Text] [Related]
53. [Cf-252 neutron therapy of cervical carcinoma: topometrical radiotherapy planning using an afterloading technic and computerized tomography].
Merkle K; Spasokukotskaya ON
Arch Geschwulstforsch; 1986; 56(3):203-10. PubMed ID: 3729681
[TBL] [Abstract][Full Text] [Related]
54. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience.
Arai T; Nakano T; Morita S; Sakashita K; Nakamura YK; Fukuhisa K
Cancer; 1992 Jan; 69(1):175-80. PubMed ID: 1727661
[TBL] [Abstract][Full Text] [Related]
55. [Combination of external beam radiotherapy and 252Cf neutron intracavitary brachytherapy for cervical cancer].
Shan JL; Lei X; Wang D; Wang G; Li L; Zhao KW
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):223-6. PubMed ID: 15924665
[TBL] [Abstract][Full Text] [Related]
56. Definitive radiation therapy in the treatment of carcinoma of the uterine cervix. Treatment results and prognostic factors.
Busch M; Dühmke E; Kuhn W; Teichmann A
Strahlenther Onkol; 1991 Nov; 167(11):628-37. PubMed ID: 1962276
[TBL] [Abstract][Full Text] [Related]
57. [Reoxygenation of tumors of the uterine cervix during combined radiotherapy using low dose gamma-neutron irradiation with californium-252].
Tacev T; Rasovská O; Strnad V; Krystof V; Prokes B; Vacek A
Cesk Radiol; 1989 Mar; 43(2):125-35. PubMed ID: 2731302
[TBL] [Abstract][Full Text] [Related]
58. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
59. Perioperative neutron brachytherapy with californium-252.
Vtyurin BM; Medvedev VS; Ivanov VN; Anikin VA; Ivanova LF
Int J Radiat Oncol Biol Phys; 1992; 23(4):873-9. PubMed ID: 1535620
[TBL] [Abstract][Full Text] [Related]
60. Cf-252 neutron brachytherapy of short duration for bulky neck tumors.
Maruyama Y; Beach JL
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):761-770. PubMed ID: 3011711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
